US2996427A - Anaesthetic consisting of nitrous oxide and halothane - Google Patents
Anaesthetic consisting of nitrous oxide and halothane Download PDFInfo
- Publication number
- US2996427A US2996427A US775117A US77511758A US2996427A US 2996427 A US2996427 A US 2996427A US 775117 A US775117 A US 775117A US 77511758 A US77511758 A US 77511758A US 2996427 A US2996427 A US 2996427A
- Authority
- US
- United States
- Prior art keywords
- halothane
- nitrous oxide
- anaesthetic
- liquid
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
Definitions
- This invention relates to a method of vaporizing volatile anaesthetic agents and more particularly to the vaporizing of halothane and to compositions including halothane.
- Halothane 1:1:1-trifiuoro-2-bromo-2-chloroethane of the formula CF CHBrCl) described in United States Patent 2,849,502 is a volatile and very potent general anaesthetic. Because of its high vapor pressure, Ostwald coefiicient and the fact that moderately deep anaesthesia can be produced with a concentration of 10 nag/100 ml. of blood, halothane requires very careful control of the administered concentration.
- halothane is administered at concentrations of up to 2.5% by volume for induction, and, from 0.8% to 1.5% by volume for maintenance. Concentrations of as little as 2.5% can be dangerous.
- the applicants have now developed a method which provides for effective control of the concentration of halothane and which does not require any special apparatus.
- the applicants method comprises bringing liquid halothane together in a vessel under pressure with nitrous oxide, a gas which liquifies at ambient temperature. In this way a constant and known concentration of the liquid halothane will be obtained which is about 0.5% by volume halothane to nitrous oxide at ambient temperature (20 C.).
- the volatile halothane and the nitrous oxide now liquid will vaporize according to the partial pressures of these substances as long as both remain in the liquid state.
- the anaesthetic mixture may be administered in the normal manner.
- the gaseous mixture of halothane and diluent gas is drawn ofr" from the pressure vessel through a reducing valve and mixed with at least 20% by volume of oxygen and reaches the patient through any standard anaesthetic machine.
- Halothane is a known inflammable liquid whose vapor does not burn or explode with any proportion of oxygen.
- the Ostwald coeificient is 3.06 at 37 C.
- the gaseous diluent, nitrous oxide, is also an anaesthetic, is non-inflammable and has a vapor pressure when liquid which makes it suitable for the purposes of the present invention.
- liquid mixture of halothane and nitrous oxide in accordance with the invention is stable indefinitely.
- Example A size D cylinder 250 US. gallons was filled with 28.04 cc. of liquid halothane and 250 (at F. and 745 pounds per square inch pressure) -U.S. gallons of nitrous oxide.
- the resultant concentration of halothane in nitrous oxide was 0.628% volume by volume. This concentration was first calculated theoretically and then shown by analysis to be correct, both immediately after the cylinder was filled, then again after six months storage of the cylinder at ambient temperature. This indicates the stability of the mixture necessary to its use in anaesthetization.
- a mixture of liquefied nitrous oxide and liquid halothane maintained under pressure.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
United States atent O 2,996,427 ANAESTHETIC CONSISTING OF NITROUS OXIDE AND HALOTHANE James G. Robson, 301 Victoria Drive, Baie dUrfee, Quebec, Canada, and Peter J. L. Welt, 3737 Hutchisou St., Montreal, Quebec, Canada No Drawing. Filed Nov. 20, 1958, Ser. No. 775,117 1 Claim. (Cl. 167-52) This invention relates to a method of vaporizing volatile anaesthetic agents and more particularly to the vaporizing of halothane and to compositions including halothane.
Halothane 1:1:1-trifiuoro-2-bromo-2-chloroethane of the formula CF CHBrCl) described in United States Patent 2,849,502 is a volatile and very potent general anaesthetic. Because of its high vapor pressure, Ostwald coefiicient and the fact that moderately deep anaesthesia can be produced with a concentration of 10 nag/100 ml. of blood, halothane requires very careful control of the administered concentration.
Normally, halothane is administered at concentrations of up to 2.5% by volume for induction, and, from 0.8% to 1.5% by volume for maintenance. Concentrations of as little as 2.5% can be dangerous. These figures are based on the administration of halothane as the sole anaesthetic.
At the present time, it is common practice to control the concentration of the halothane during administration by using special vaporizing equipment. This equipment is capable of control of the concentration to within about 0.2%. However, it is complicated, having to compensate for both flow rate and temperature, and consequently expensive.
Applicants development The applicants have now developed a method which provides for effective control of the concentration of halothane and which does not require any special apparatus. The applicants method comprises bringing liquid halothane together in a vessel under pressure with nitrous oxide, a gas which liquifies at ambient temperature. In this way a constant and known concentration of the liquid halothane will be obtained which is about 0.5% by volume halothane to nitrous oxide at ambient temperature (20 C.). The volatile halothane and the nitrous oxide (now liquid) will vaporize according to the partial pressures of these substances as long as both remain in the liquid state.
Using the applicants method, the anaesthetic mixture may be administered in the normal manner. The gaseous mixture of halothane and diluent gas is drawn ofr" from the pressure vessel through a reducing valve and mixed with at least 20% by volume of oxygen and reaches the patient through any standard anaesthetic machine.
Halothane is a known inflammable liquid whose vapor does not burn or explode with any proportion of oxygen. The liquid boils at 502 C. (760 mm. Hg), has a specific gravity of 1.86 and a vapor pressure of 243 mm. Hg at 20 C. The Ostwald coeificient is 3.06 at 37 C. The gaseous diluent, nitrous oxide, is also an anaesthetic, is non-inflammable and has a vapor pressure when liquid which makes it suitable for the purposes of the present invention.
The liquid mixture of halothane and nitrous oxide in accordance with the invention is stable indefinitely.
The following example is further illustrative of the invention in preferred aspects.
Example A size D cylinder (250 US. gallons) was filled with 28.04 cc. of liquid halothane and 250 (at F. and 745 pounds per square inch pressure) -U.S. gallons of nitrous oxide. The resultant concentration of halothane in nitrous oxide was 0.628% volume by volume. This concentration was first calculated theoretically and then shown by analysis to be correct, both immediately after the cylinder was filled, then again after six months storage of the cylinder at ambient temperature. This indicates the stability of the mixture necessary to its use in anaesthetization.
We claim:
For use in anesthetizing a patient with an inhalation anesthetic, a mixture of liquefied nitrous oxide and liquid halothane maintained under pressure.
Raventos: Survey of Anesthesiology, June 1957, pp. 178486.
J.A.M.A., Oct. 5, 1957, vol. 165, No. 5, p. 624.
Bryce-Smith: December 1957, Survey of Anesthesiol- I ogy, pp. 610-612.
Dripps: Introduction to Anesthesia, W. B. Saunders Co., 1957, PP. 27-30.
Andriani: The Chemistry of Anesthesia, 1946, page 52.
UNITED STATES PATENT OFFICE I CERTIFICATE OF CORRECTION Patent No. 2,996 427 August 15, 1961 v James Go Robson et a1;
or eppears in the above numbered pat- It is hereby certified that err said Letters Patent should read as ent requiring correction and that the corrected below.
line 45, for 005% read 0.6% ;3 column 2 Column l read nonflammable line 6 for "inflammable Signed and sealed this 15th day of January 1963.
(SEAL) Attest:
DAVID L. LADD ERNEST W. SWIDER Commissioner of Patents Attesting Officer
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US775117A US2996427A (en) | 1958-11-20 | 1958-11-20 | Anaesthetic consisting of nitrous oxide and halothane |
GB3920459A GB940777A (en) | 1958-11-20 | 1959-11-19 | Improvements in and relating to inhalation anaesthetic compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US775117A US2996427A (en) | 1958-11-20 | 1958-11-20 | Anaesthetic consisting of nitrous oxide and halothane |
Publications (1)
Publication Number | Publication Date |
---|---|
US2996427A true US2996427A (en) | 1961-08-15 |
Family
ID=25103378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US775117A Expired - Lifetime US2996427A (en) | 1958-11-20 | 1958-11-20 | Anaesthetic consisting of nitrous oxide and halothane |
Country Status (1)
Country | Link |
---|---|
US (1) | US2996427A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3192106A (en) * | 1961-08-15 | 1965-06-29 | British Oxygen Co Ltd | Gas mixtures containing nitrous oxide |
US3266986A (en) * | 1962-05-09 | 1966-08-16 | Ferrosan Ab | Hypnotic composition containing reaction product of chloral hydrate and acetylglycineamide |
US3278609A (en) * | 1960-08-19 | 1966-10-11 | Boehringer Sohn Ingelheim | Alkine diols and processes of preparation |
US3876773A (en) * | 1973-05-15 | 1975-04-08 | British Oxygen Co Ltd | Gas mixtures containing nitrous oxide |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2849502A (en) * | 1954-10-20 | 1958-08-26 | Ici Ltd | 1, 1, 1-trifluoro-2-bromo-2-chloroethane and a process of making it |
-
1958
- 1958-11-20 US US775117A patent/US2996427A/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2849502A (en) * | 1954-10-20 | 1958-08-26 | Ici Ltd | 1, 1, 1-trifluoro-2-bromo-2-chloroethane and a process of making it |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3278609A (en) * | 1960-08-19 | 1966-10-11 | Boehringer Sohn Ingelheim | Alkine diols and processes of preparation |
US3192106A (en) * | 1961-08-15 | 1965-06-29 | British Oxygen Co Ltd | Gas mixtures containing nitrous oxide |
US3266986A (en) * | 1962-05-09 | 1966-08-16 | Ferrosan Ab | Hypnotic composition containing reaction product of chloral hydrate and acetylglycineamide |
US3876773A (en) * | 1973-05-15 | 1975-04-08 | British Oxygen Co Ltd | Gas mixtures containing nitrous oxide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB967930A (en) | Gas mixtures containing nitrous oxide | |
US2996427A (en) | Anaesthetic consisting of nitrous oxide and halothane | |
Henderson et al. | Cyclopropane: a new anesthetic | |
US3876773A (en) | Gas mixtures containing nitrous oxide | |
Prys-Roberts | Principles of treatment of poisoning by higher oxides of nitrogen | |
Collom et al. | Detection of glue constitutents in fatalities due to “glue sniffing” | |
US3097133A (en) | Anaesthetic 1: 1: 1: 3: 3: 3-hexafluoro-2-halopropane | |
Romagnoli et al. | A safe and economical method of administering fluothane in closed circuit anaesthesia | |
US4113883A (en) | Anaesthetic compositions | |
WOLFSON | Closed circuit anaesthesia by intermittent injections of halothane | |
US3027299A (en) | Anesthetic composition comprising halovinyl ether and halo hydrocarbon | |
US3729567A (en) | 1,1,5-trihydro-perfluoropentane as an inhalation anesthetic | |
Schober et al. | An innovative anaesthesia machine: the closed system | |
Thomas et al. | Clinical and Laboratory Data on Ether-Cyclopropane-Oxygen-Helium Mixtures. | |
US3034959A (en) | Halogenated propane inhalation anesthetic mixtures | |
US3506768A (en) | Composition and method for anesthetizing using 3-chloro-1,1,2,2,3-pentafluoropropane | |
Barbour | Pharmacological action of inhalation anesthetics | |
Mushin et al. | Cyclopropane in Non-explosive Mixture for Out-patient Anaesthesia | |
Dixon et al. | Fluothane and other non-explosive halogenated hydrocarbons in clinical anaesthesia | |
US3749798A (en) | 1-chloro-1-hydroperfluorobutyl difluoromethyl ether as an inhalation anesthetic | |
US3242047A (en) | 1, 1-dichloro-2, 2-difluoropropane anaesthetic | |
Thomas et al. | Clinical Experiences in The Prevention of Cyclopropane-Oxygen Explosions by the Addition of Helium. | |
deNava et al. | Explosion Hazard of Intragastric Anesthetic Mixtures | |
US2930732A (en) | Anesthetics | |
Hazan | FLUOROMAR |